Opinion
No. 452, 2019
04-30-2020
John SOLAK, Derivatively ON BEHALF OF ULTRAGENYX PHARMACEUTICAL INC., Plaintiff-below, Appellant, v. Daniel G. WELCH, Emil D. Kakkis, M.D., Ph.D., William Aliski, Deborah Dunsire, M.D., Lars Ekman, M.D., Ph.D., Matthew K. Fust, Michael Narachi and Clay B. Siegall, Ph.D., Defendants-below, Appellees, and Ultragenyx Pharmaceutical Inc., a Delaware Corporation, Nominal Defendant-below, Appellee.
ORDER
Karen L. Valihura Justice
Now this 30th day of April, 2020 having considered this matter on the briefs of the parties and the record below, and having concluded that the same should be affirmed on the basis of and for the reasons assigned by the Court of Chancery in its Memorandum Opinion dated October 30, 2019;
NOW, THEREFORE IT IS ORDERED that the judgment of the Court of Chancery be, and the same hereby is, AFFIRMED.